MRC1 and neoplasm: Meanwhile, CM from anti-ILT4- or anti-PD-L1-pretreated tumor cells decreased CD163 and CD206 levels in TAMs, and combined antibody group displayed the lowest CD163 and CD206 expression (Figure S4G-I).